Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs. | Front Bioeng Biotechnol | 2022 | 36324900 | PubTator, text mining | PubMed |
| Spatiotemporal and genetic regulation of A-to-I editing throughout human brain development. | Cell Rep | 2022 | 36323256 | PubTator, text mining | PubMed |
| Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities. | Asian J Pharm Sci | 2022 | 36320315 | PubTator, text mining | PubMed |
| RNA binding proteins in MLL-rearranged leukemia. | Exp Hematol Oncol | 2022 | 36307883 | PubTator, text mining | PubMed |
| Single-molecule identification of the target RNAs of different RNA binding proteins simultaneously in cells. | Genes Dev | 2022 | 36302554 | PubTator, text mining | PubMed |
| Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation. | Cells | 2022 | 36291166 | PubTator, text mining | PubMed |
| Epitranscriptome Analysis of Oxidative Stressed Retinal Epithelial Cells Depicted a Possible RNA Editing Landscape of Retinal Degeneration. | Antioxidants (Basel) | 2022 | 36290689 | PubTator, text mining | PubMed |
| ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit. | Proc Natl Acad Sci U S A | 2022 | 36282916 | PubTator, text mining | PubMed |
| Unveiling the functional and evolutionary landscape of RNA editing in chicken using genomics and transcriptomics. | Zool Res | 2022 | 36266925 | PubTator, text mining | PubMed |
| Insights from DOCK2 in cell function and pathophysiology. | Front Mol Biosci | 2022 | 36250020 | PubTator, text mining | PubMed |
| ADAR activation by inducing a syn conformation at guanosine adjacent to an editing site. | Nucleic Acids Res | 2022 | 36243986 | PubTator, text mining | PubMed |
| USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma. | Oncogene | 2022 | 36243803 | PubTator, text mining | PubMed |
| Retasking of canonical antiviral factors into proviral effectors. | Curr Opin Virol | 2022 | 36242894 | PubTator, text mining | PubMed |
| New CRISPR Tools to Correct Pathogenic Mutations in Usher Syndrome. | Int J Mol Sci | 2022 | 36232969 | PubTator, text mining | PubMed |
| Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment. | Mol Oncol | 2022 | 36221913 | PubTator, text mining | PubMed |
| Identification and analysis of microRNA editing events in recurrent bladder cancer based on RNA sequencing: MicroRNA editing level is a potential novel biomarker. | Front Genet | 2022 | 36199571 | PubTator, text mining | PubMed |
| Programmable RNA sensing for cell monitoring and manipulation. | Nature | 2022 | 36198803 | PubTator, text mining | PubMed |
| Reduced RNA adenosine-to-inosine editing in hippocampus vasculature associated with Alzheimer's disease. | Brain Commun | 2022 | 36196083 | PubTator, text mining | PubMed |
| Breakdown of the central synapses in C9orf72-linked ALS/FTD. | Front Mol Neurosci | 2022 | 36187344 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers?page=18